Teva's Bid To Block Generic MS Drug Is Premature, FDA Says
The U.S. Food and Drug Administration on Monday urged a D.C. federal judge to dismiss Teva Pharmaceutical Industries Ltd.'s suit seeking to prevent the agency from approving generic versions of Teva's...To view the full article, register now.
Already a subscriber? Click here to view full article